Biomarkers
Molecular Report Review
Interpretation of NGS, biomarker, pathology, and molecular-testing results in clinical context.
Independent cancer-biology insight
Clearer interpretation of complex oncology reports.
Precision Oncology Advisory helps patients, families, and care teams organize molecular findings, biomarker results, pathology details, and published evidence into a clear scientific review for discussion with the treating oncology team.
Genomic report review
Biomarker interpretation
Clinical-trial context
Molecular profile review
Variants, fusions, amplifications, resistance markers, immune features, and tumour context.
Evidence-to-question summary
A practical document highlighting what the biology may mean and what to ask the oncology team next.
About
Advisory support for better-informed oncology conversations.
Modern cancer reports can contain dozens of genomic and biomarker findings. The challenge is not only obtaining data, but understanding which results may be clinically meaningful in a specific cancer type, stage, treatment history, and evidence landscape.
What POA does
We translate complex molecular and clinical information into a structured scientific summary. The goal is to help people prepare for more focused conversations with licensed oncology professionals.
Precision Oncology Advisory provides educational interpretation and evidence organization. It does not diagnose, prescribe, or replace medical care.
Advisory Areas
Focused review of the science behind the case.
Each review is tailored to the available documents and the question being asked.
Evidence
Evidence Landscape
Plain-language summary of relevant therapeutic concepts, guidelines, studies, and limitations.
Trials
Trial Relevance Scan
Identification of biologically relevant clinical-trial themes and eligibility questions to verify.
Questions
Oncologist Question List
Concise questions patients can bring to their treating team to clarify next steps.
Process
A quiet, structured review workflow.
Designed for confidential, low-profile advisory work while the brand remains in a stealth-stage format.
Submit documents
Share reports, diagnosis details, treatment history, and your main question.
Scientific review
Key biomarkers, pathways, resistance patterns, and evidence are assessed together.
Written summary
You receive a clear, organized explanation with evidence notes and discussion points.
Clinical discussion
Use the review to support a focused conversation with the treating oncology team.
Use Cases
Questions this advisory review can help organize.
“What does this mutation mean?”
Contextual explanation of variants, fusions, amplifications, MSI, TMB, HRD, PD-L1, and other biomarkers.
“Is this finding actionable?”
Clarifies whether a biomarker has approved, investigational, off-label, or resistance-related relevance.
“What should we ask next?”
Creates a short, practical question list for the oncologist or molecular tumour board.
“Are trials worth discussing?”
Highlights biologically relevant trial categories and the eligibility details that need confirmation.
Contact
Request a confidential review.
Use this form to request a confidential oncology advisory review. Submissions are sent directly to the Precision Oncology Advisory email address.
Email: info@poateam.com
Availability: Remote review by secure phone or video